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The field of epigenomics has been transformed
by chromatin immunoprecipitation approaches that
provide for the localization of a defined protein or
posttranslationally modified protein to specific chro-
mosomal sites. While these approaches have helped
us conceptualize epigenetic mechanisms, the field
has been limited by the inability to define features
such as the proteome and histone modifications at
a specific genomic locus in an unbiased manner.
We developed an unbiased approach whereby a
unique native genomic locus was isolated, which
was followed by high-resolution proteomic iden-
tification of specifically associated proteins and his-
tone posttranslational modifications. This chromatin
affinity purification with mass spectrometry (ChAP-
MS) technique was used to specifically enrich a
1,000 base pair section of GAL1 chromatin under
transcriptionally active and repressive conditions,
as well as to identify the specifically bound proteins
and histone posttranslational modifications. ChAP-
MS should yield insight into the regulatory mecha-
nisms of transcription and help identify factors that
epigenetically control chromatin function.INTRODUCTION
It has long been appreciated that chromatin-associated
proteins and epigenetic factors play central roles in cell-fate re-
programming of genotypically identical stem cells through
lineage-specific transcription or repression of precise genes
and large chromosomal regions (Martin, 1981; Ho and Crabtree,
2010; Rossant, 2008). However, the hierarchy of chromatin-
templated events orchestrating the formation and inheritance
of different epigenetic states remains poorly understood at
a molecular level. Since mis-regulation of chromatin structure
and post-translational modification of histones (PTMs) is linked
to cancer and other epigenetic diseases (Jones and Baylin,
2007; Chi et al., 2010), it is imperative to establish new method-
ologies that will allow comprehensive studies and unbiased198 Cell Reports 2, 198–205, July 26, 2012 ª2012 The Authorsscreens for participants in epigenetic mechanisms. Unfortu-
nately, defining how chromatin regulators collectively assemble
and operate on a precise region of the genome is difficult to
elucidate; there are no current methodologies that allow for
determination of all proteins present at a defined, small region
of chromatin.
Technical challenges have precluded the ability to determine
positioning of chromatin factors along the chromosome. Chro-
matin immunoprecipitation (ChIP) assays have been used to
better understand genome-wide distribution of proteins and
histone modifications within a genome at the nucleosome level
(Dedon et al., 1991; Ren et al., 2000; Pokholok et al., 2005; Rob-
ertson et al., 2007; Johnson et al., 2007; Barski et al., 2007; Mik-
kelsen et al., 2007). However, major drawbacks of ChIP-based
chromatin enrichment methods include experiments that are
largely confined to examining singular histone PTMs or proteins
rather than simultaneous profiling of multiple targets, the inability
to determine the co-occupancy of particular histone PTMs, and
that ChIP is reliant on the previous identification of the molecular
target. Affinity purification approaches have been devised for the
isolation of a chromatin region (Griesenbeck et al., 2003; Agelo-
poulos et al., 2012); however, these approaches were not done
at a level for proteomic analysis and they do not provide a mech-
anism for determining the specificity of protein interactions.
More recently, groups biochemically enriching for intact chro-
matin have reported characterization of proteins associated
with large chromatin structures such as telomeres (De´jardin
and Kingston, 2009) and engineered plasmids (Akiyoshi et al.,
2009; Unnikrishnan et al., 2010); however, these approaches
do not enrich for a small integrated genomic locus and do not
employ specialized mass spectrometric techniques to detect
protein contamination in purified material.
We sought to compare differences in chromatin between the
transcriptionally active and silent states of a single genomic
locus, and developed a technology, called chromatin affinity
purification with mass spectrometry (ChAP-MS). ChAP-MS
provides for the site-specific enrichment of a given 1,000
base pair section of a chromosome followed by unambiguous
identification of both proteins and histone PTMs associated
with this chromosome section using highly selective mass spec-
trometry. Using ChAP-MS, we were able to purify chromatin at
the Saccharomyces cerevisiae GAL1 locus in transcriptionally
silent and active states. We identified proteins and combinatorial
histone PTMs unique to each of these functional states and
Figure 1. Chromatin Affinity Purification
with Mass Spectrometry
(A) The chromatin affinity purification with mass
spectrometry (ChAP-MS) approach provides for
the specific enrichment of a given chromosome
section and identification of specifically associ-
ated proteins and posttranslational modifications.
A LexA DNA affinity handle was engineered just
upstream of the GAL1 start codon in S. cerevisiae.
Strains containing the LexA DNA binding site and
a plasmid expressing LexA-PrA protein affinity
handle were cultured in glucose or galactose to
provide transcriptional repression or activation,
respectively, and subjected to in vivo chemical
crosslinking to trap protein interactions. Following
shearing of the chromatin to 1,000 bp, LexA-PrA
was affinity purified on IgG-coated Dynabeads
and coenriched proteins/posttranslational modifi-
cations were identified by high-resolution mass
spectrometry.
(B) To control for nonspecifically enriched proteins, a strain lacking the LexA DNA binding site, but containing the LexA-PrA plasmid, was cultured isotopically
heavy (13C6
15N2-lysine) in glucose or galactose and mixed equally with the corresponding isotopically light culture containing the LexA DNA binding site prior to
cell lysis. Following affinity purification (AP) and mass spectrometric analysis, nonspecifically enriched proteins were identified as a 1:1 ratio of light to heavy
lysine-containing peptides, while proteins specifically enriched with the chromosome section were identified with a higher level of isotopically light lysine-
containing peptides.validated these findings with ChIP. The ChAP-MS technique
will greatly improve the field of epigenomics as an unbiased
approach to study regulatory mechanisms on chromatin.
RESULTS
ChAP-MS Technology
Figure 1A provides an overview of the ChAP-MS approach that
was used to screen for proteins and histone PTMs associated
with a specific genomic locus in transcriptionally active or
repressive states. A LexA DNA binding site was engineered
immediately upstream of the GAL1 start codon in a S. cerevisiae
strain constitutively expressing a LexA-Protein A (LexA-PrA)
fusion protein. The LexA DNA binding site directs the localization
of the LexA-PrA protein affinity ‘‘handle’’ to the GAL1 promoter
in vivo. The positioning of the LexA DNA was designed so we
could specifically enrich for chromatin-associated proteins and
histone PTMs regulating gene expression near the transcrip-
tional start site of GAL1. This strain was cultured in glucose to
repress gene transcription, or galactose to activate gene tran-
scription. Following in vivo chemical crosslinking to preserve
the native protein-protein interactions at GAL1 promoter chro-
matin, the chromatin was sheared to 1,000 base pair sections.
The PrA moiety of the LexA-PrA fusion protein was then used to
affinity purify the 1,000 base pair section of chromatin at the 50
end of the GAL1 gene for high resolution mass spectrometric
identification of proteins and histone PTMs. We anticipated
culturing these cells in glucose would result in the isolation of
proteins and PTMs correlated to silent chromatin, while culturing
cells in the presence of galactose would purify histone PTMs and
proteins, like RNA polymerase, that are involved with active gene
transcription.
The GAL1 gene is present at one copy per haploid cell; due to
the relative low abundance of the targeted chromatin region in
cellular lysates, we fully anticipated that proteins nonspecificallyassociating with GAL1 chromatin would complicate our analysis
of the resulting purified material. Copurification of nonspecifi-
cally associating proteins is one of the major complications of
affinity purifications; however, isotopic labeling of media pro-
vides a means to gauge in vivo protein-protein interactions and
quantitate differences in peptide abundance (Smart et al.,
2009; Tackett et al., 2005a). We previously developed a variation
of this labeling technique called iDIRT (isotopic differentiation
of interactions as random or targeted) that provides a solution
for determining which coenriched proteins are specifically or
nonspecifically associated with a complex of proteins (Smart
et al., 2009; Tackett et al., 2005a). The iDIRT technique was
adapted (as described in Figure 1B) to control for proteins
nonspecifically enriching with LexA-PrA and the resin. By using
this adaptation of iDIRT on chromatin enriched from active and
repressed chromatin states, the proteins nonspecifically enrich-
ingwith the isolatedGAL1 chromatin sectionwere identified. The
strain containing the LexA DNA binding site and LexA-PrA fusion
protein was cultured in isotopically light media, while a strain
lacking the LexA DNA binding site (but still containing the
LexA-PrA fusion protein) was cultured in isotopically heavy
media (13C6
15N2-lysine). Following isolation of the cells, the light
and heavy strains were mixed and colysed. The growth and
mixing of light/heavy strains was performed separately under
glucose and galactose growth conditions. The affinity purifica-
tion of the GAL1 chromatin was performed from this mixture of
light/heavy lysates. Proteins and histone PTMs specifically asso-
ciated with the GAL1 chromatin containing the LexA DNA
binding site were isotopically light as they arose from the cells
grown in light media. Proteins that were nonspecific to the puri-
fication were a 1:1 mix of light and heavy as they were derived
equally from the light and heavy lysates. Analysis of peptides
from the enriched proteins with high-resolution mass spec-
trometry was used to determine the level of isotopically light
and heavy proteins, thereby determining whether the detectedCell Reports 2, 198–205, July 26, 2012 ª2012 The Authors 199
Figure 2. Introduction of a DNA Affinity Handle for Purification of
a Specific Chromosome Section
(A) S. cerevisiae strain LEXA::GAL1 pLexA-PrA was created by insertion of
a LEXA DNA binding site upstream of the GAL1 start codon via homologous
recombination. The pLexA-PrA plasmid was introduced into this strain and the
constitutive expression of the LexA-PrA fusion protein was confirmed by
western blotting for PrA.
(B) Introduction of the LEXA DNA binding site does not impede GAL1 tran-
scription. cDNA from wild-type or LEXA::GAL1 pLexA-PrA strains grown in
glucose or galactose was used as a template for real time PCR analysis of
GAL1 versus ACT1 gene transcription. Error bars are the SE of triplicate
analyses.protein was either a specific in vivo constituent of GAL1 chro-
matin or a nonspecific contaminant.
Affinity Purification of a Specific Chromosome Section
To provide for enrichment of a specific chromosome section,
a DNA affinity handle was engineered at the GAL1 gene in
S. cerevisiae (Figure 2A). A LexA DNA binding site was inserted
via homologous recombination just upstream of the GAL1 start
codon to create strain LEXA::GAL1. To create this strain,
GAL1 was genomically deleted with URA3 in the W303a back-
ground, and then the GAL1 gene was reinserted with the
upstream LEXA DNA sequence by homologous recombination.
A plasmid constitutively expressing LexA-PrA was introduced
into the strain to create LEXA::GAL1 pLexA-PrA (Figure 2A).
This strain provides a DNA affinity handle at the GAL1 gene
and a protein affinity handle for specific enrichment. To deter-
mine if insertion of this LexA DNA binding site at GAL1 affected
gene transcription, we cultured LEXA::GAL1 pLexA-PrA in
glucose to repress gene transcription at GAL1, and separately
in galactose to activate transcription. From these growths, we
prepared cDNA and used real-time PCR to measure the activa-
tion of GAL1 transcription in the presence of galactose (Fig-
ure 2B). Insertion of the LexA DNA binding site just upstream
of the GAL1 start codon did not drastically affect the activation
of gene transcription; thus, this strain was used for ChAP-MS
purification of GAL1 chromatin in the transcriptionally active
and silent states.
To determine the effectiveness of isolation ofGAL1 chromatin,
we analyzed the stringency and specificity of different purifica-
tion conditions. Purification of protein complexes under increas-
ing stringencies such as high salt levels provides for the isolation
of fewer nonspecifically interacting proteins (Smart et al., 2009;
Taverna et al., 2006). Since the proteins purified withGAL1 chro-
matin will be chemically crosslinked, the stringency of the purifi-
cation can potentially be quite high. Indeed, ChIP-qPCR against
GAL1 showed that the PrA-based purification can survive rela-200 Cell Reports 2, 198–205, July 26, 2012 ª2012 The Authorstively stringent conditions (Figure 3A). From these studies, 1 M
NaCl and 1 M urea were selected for future purifications, as
these conditions are quite stringent and provide for enrichment
of the GAL1 chromatin. Using an identical ChIP approach, the
specificity of the GAL1 chromatin enrichment was determined
(Figure 3B). Using primers targeted to the indicated regions of
chromatin surrounding GAL1, we detected that the first 1,000
base pair section of theGAL1 gene was indeed enriched. Enrich-
ment of GAL1 chromatin was observed at a similar level under
glucose and galactose growth conditions (Figure 3C). The
slightly less efficient isolation under galactose growth conditions
may reflect availability of the DNA affinity site due to alterations in
chromatin structure.
ChAP-MS Analysis of Transcriptionally Active and Silent
GAL1 Chromatin
Strain LEXA::GAL1 pLexA-PrA was subjected to the ChAP-MS
procedure as outlined in Figure 1. Strain LEXA::GAL1 pLexA-
PrA was grown in isotopically light media, while strain pLexA-
PrA was grown in isotopically heavy media. Following growth
of each strain to mid-log phase, the cells were treated with
1.25% formaldehyde to trap protein interactions on the chromo-
somes. We have recently published a detailed analysis of the
amount of formaldehyde crosslinking required to preserve the
in vivo state of chromatin during affinity purifications (Byrum
et al., 2011a, 2011b). Approximately 2.5 3 1011 LEXA::GAL1
pLexA-PrA cells were mixed with an equivalent amount of isoto-
pically heavy pLexA-PrA cells (separately for media containing
glucose and galactose) and then subjected to lysis under cryo-
genic conditions with a Retch MM301 ball mill (Tackett et al.,
2005a). Lysates were suspended in 20 mM HEPES (pH 7.4),
0.1% Tween 20, 1 M NaCl, 1 M urea, and 2 mM MgCl2. Lysates
were then subjected to sonication and chromatin was sheared
to sections of 1,000 base pairs. LexA-PrA was collected on
IgG-coated Dynabeads and proteins coenriching were resolved
by SDS-PAGE and visualized by Coomassie staining (Figure 4A).
Gel lanes were sliced into 2 mm sections and subjected to in-
gel trypsin digestion (Smart et al., 2009; Tackett et al., 2005a,
2005b). Peptides from proteins were identified by high-resolu-
tion mass spectrometry with a Thermo Velos Orbitrap mass
spectrometer equipped with a Waters nanoACQUITY UPLC
system. Proteins and PTM-containing peptides were identified
and the level of isotopically light to heavy peptide was calcu-
lated with Mascot Distiller (Smart et al., 2009). Representative
spectra are shown in Figure 4B. Major bands observed in
the gel lanes correspond to the affinity purification protein
LexA-PrA and IgG chains as anticipated. Other proteins iden-
tified correspond to specifically and nonspecifically enriched
proteins. Tables S1, S2, S3, and S4 list the proteins identified
and percent isotopically light peptides (352 proteins from
the glucose ChAP-MS and 399 proteins from the galactose
ChAP-MS).
Once proteins were identified, a baseline was established for
nonspecifically associated proteins in accordance to our previ-
ously published iDIRT approach (Smart et al., 2009). Nonspecif-
ically enriching ribosomal proteins were used to establish the
nonspecifically associating baseline (Smart et al., 2009). The
average percent isotopically light peptides from 20 ribosomal
Figure 3. Efficiency of GAL1 Chromatin
Purification
(A) The effect of buffer stringency on purification of
LexA-PrA with associated chromatin was evalu-
ated with ChIP. Strain LEXA::GAL1 pLexA-PrA
was subjected to ChIP using the following buffer
with the reagents indicated on the graph: 20 mM
HEPES (pH 7.4), 0.1% Tween 20, and 2 mM
MgCl2. Enrichment of GAL1 DNA relative to ACT1
DNA was monitored by real-time PCR.
(B) ChIP was used to measure the specificity
of enrichment of LexA-PrA bound chromatin.
Enrichment was monitored by real-time PCR with
primer sets at the indicated chromosomal loca-
tions.
(C) GAL1 chromatin is enriched in both glucose
and galactose growth conditions. The relative
efficiency of GAL1 enrichment was monitored by
real-time PCR with primers targeted to the ‘‘0’’
position in panel B and to ACT1. The SE is indi-
cated.proteins from the glucose and galactose growth conditions were
used to establish this nonspecifically associating baseline
(Table S5). This resulted in a nonspecifically associating baseline
of 49.93% ± 2.12% light for the glucose ChAP-MS and 66.8% ±
7.1% light for the galactose ChAP-MS (Figure 5). Proteins were
categorized as specifically associating with GAL1 chromatin if
the percent light was greater than 2 SDs above the ribosomal
level (Smart et al., 2009). Figure 5 shows the proteins and histone
PTMs specifically enriched with GAL1 chromatin under glucose
and galactose growth conditions. Tables S6 and S7 list proteins
that were identified as specifically enriched in both the glucose
and galactose ChAP-MS analyses. Specifically enriched pro-
teins or histone PTMs known to be involved in transcriptional
regulation are listed in Figure 5. For the glucose and galactose
ChAP-MS analyses, 11 and 17 (respectively) additional proteins
were detected as specifically enriched (Figure 5, Tables S6
and S7). These additional proteins are abundant metabolic and
heat shock proteins that are typical contaminants and false
positives for this study. However, narrowing down 352 proteins
identified from the glucose ChAP-MS and 399 proteins from
the galactose ChAP-MS to 12 proteins and 27 proteins/PTMs
specifically enriched produced a short list of candidates that
was easily validated.
The ChAP-MS analyses of GAL1 chromatin revealed asso-
ciation of Gal3, Spt16, Rpb1, Rpb2, H3K14ac, H3K9acK14ac,
H3K18acK23ac, H4K5acK8ac, and H4K12acK16ac under tran-
scriptionally active conditions, while transcriptionally repressive
conditions showed the enrichment of H3K36me3. In order to
validate our approach, standard ChIP was performed to specific
interactions detected in the transcriptionally active and silent
chromatin state atGAL1 (Figure 6). These ChIP experiments vali-
dated the proteins and PTMs found associated with the tran-
scriptionally active and repressed states of GAL1 chromatin
determined from the ChAP-MS approach.DISCUSSION
The chromatin biology and epigenomics research communities
have been limited to biased technologies that restrict targeted
genome localization studies to previously identified proteins or
histone PTMs. Here we have described a newly developed tech-
nology called ChAP-MS that circumvents this limitation by
providing for isolation of a1,000 base pair section of a chromo-
some for proteomic identification of specifically bound proteins
and PTMs. In essence, the ChAP-MS approach allows one to
take a ‘‘molecular snapshot’’ of chromatin dynamics at a specific
genomic locus. Furthermore, employing this approach to target
other chromatin regions will likely provide unprecedented insight
on a variety of epigenetic regulatory mechanisms, chromatin
structure, and genome metabolism.
Validation of the ChAP-MS Approach
TheChAP-MS approachwas validated on thewell-studiedGAL1
locus in S. cerevisiae. The GAL1 gene is activated for gene
transcription in the presence of galactose, while glucose
represses transcription. Accordingly, we rationalized that a puri-
fied 1,000 base pair section of chromatin at the 50 end of the
GAL1 gene from cells grown in galactose would contain histone
PTMs correlated with active transcription and cellular machinery
necessary for transcription, while the same chromatin section
from cells grown in glucose would be enriched with histone
PTMs associated with transcriptional repression. Prior publica-
tions have documented that H3 acetylation is enriched on
the 50 end of the active galactose-induced GAL1 gene, while
in the presence of glucose it contains H3K36me3 (Shukla
et al., 2006; Houseley et al., 2008). Our results with ChAP-MS
support each of these prior findings (Figure 5). Furthermore,
we identified the presence of doubly acetylated histones
(H3K9acK14ac, H3K18acK23ac, H4K5acK8ac, H4K12acK16ac)Cell Reports 2, 198–205, July 26, 2012 ª2012 The Authors 201
Figure 4. ChAP-MS Analysis of GAL1 Chromatin
(A) Enrichment ofGAL1 chromatin under transcriptionally repressive glucose and active galactose growth conditions. Strain LEXA::GAL1 pLexA-PrAwas grown
in either glucose or galactose and subjected to affinity purification of GAL1 chromatin via LexA-PrA as detailed in Figure 1. Addition of an equivalent amount of
isotopically heavy (13C6
15N2-lysine) cells lacking the LexA DNA binding site provided for the identification of proteins specifically enriched with GAL1 chromatin.
Proteins coenriching with LexA-PrA were resolved by SDS-PAGE and visualized by Coomassie-staining. Each gel lane was sliced into 2 mm sections. Gel slices
were treated with trypsin and resulting peptides were analyzed by high-resolution mass spectrometry.
(B) Representative high-resolution mass spectra from proteins and histone posttranslational modifications identified from the purification of transcriptionally
active GAL1 chromatin.during transcriptional activation. This demonstrates how ChAP-
MS can be used to study the combinatorial ‘‘code’’ of histone
modifications at given chromosome regions without the need
for prior identification of PTMs, PTM-specific antibodies, or
sequential chromatin pull-downs. Considering H4K12acK16ac
for example, the identification of the double acetylation is unique
to the ChAP-MS approach as antibodies to this double acetyla-
tion do not exist, thus one could not have performed a biased
ChIP analysis. Additionally, it has been reported that commer-
cially available antibodies to single acetylation at H4K12 or
H4K16 are cross-reactive with other H4 acetylations and that
double acetylation of H4K12K16 significantly alters the speci-
ficity of the antibody to the singly acetylated sites (Bock et al.,202 Cell Reports 2, 198–205, July 26, 2012 ª2012 The Authors2011)—a limitation specific to antibodies used in biased ChIP
studies and not to the unbiased ChAP-MS approach that
uses quantitative mass spectrometric readout. The ChAP-MS
approach simultaneously identified the presence of RNA poly-
merase (Rpb1, Rpb2) and FACT component Spt16 (which aids
in reorganizing chromatin for RNA pol activity) under these tran-
scriptionally active conditions. Also of interest was the identifica-
tion of Gal3 at actively transcribing GAL1, which has previously
been shown to inhibit the repressive activity of Gal80 at the
GAL10/GAL1 locus (Platt and Reece, 1998). We have demon-
strated how the ChAP-MS approach can be utilized to study
chromatin dynamics atGAL1 under different states of gene tran-
scription. Of particular interest for future functional studies will be
Figure 5. Proteins and Histone Posttranslational Modifications
Enriched with GAL1 Chromatin
Proteins and histone posttranslational modifications identified from the ChAP-
MS analysis of GAL1 chromatin in the transcriptionally active galactose and
repressive glucose growth conditions are listed in accordance to their percent
isotopically light. Proteins or posttranslational modifications were considered
specifically enrichedwithGAL1 chromatin if the percent isotopically light was 2
SDs from the nonspecific baseline established by the average of contaminant
ribosomal proteins. Other proteins shown to be specifically enriched, but not
correlated to gene transcription, are averaged together and listed individually
in Tables S6 and S7. The number of proteins averaged is shown in paren-
theses. The SD is indicated.
Figure 6. Validation of Proteins and Histone Posttranslational
Modifications on GAL1 Chromatin
ChIP was targeted to Gal3-TAP, Spt16-TAP, Rpb2-TAP, H3K14ac, and
H3K36me3 under transcriptionally active galactose and repressive glucose
growth conditions. ChIP to general H3 was used as a nucleosome occupancy
control for each histone posttranslational modification ChIP. Enrichment of the
50 end of GAL1 DNA relative to ACT1 DNA was monitored by real-time PCR.
The SE is indicated.the upstream activating sequencewhich binds theGal4 activator
and Gal80 repressor which will allow us to better understand the
events surrounding the switch from repression to activation
at GAL1 and GAL10, as well as the middle and 30 end of GAL1
to understand the processes of elongation and termination,
respectively.
Utility of ChAP-MS as a General Tool for Studying
Chromatin Biology
The ChAP-MS technology presented here demonstrates the
ability to purify a unique chromosome section on the order of
four to five nucleosomes in length from an in vivo source that
can subsequently be subjected to sensitive proteomic studies.
ChAP-MS has numerous advantages relative to traditional
ChIP—including the ability to unbiasedly detect proteins/PTMs
at a specific genomic locus and the identification of combinato-
rial histone modifications on a single histone molecule. Further-
more, ChAP-MS only requires approximately an order of magni-
tude more cells relative to biased ChIP studies, which is a huge
advantage if you factor in doing more than ten blind ChIP studies
at a given region (chances are one would invest heavily in many
antibodies for many proteins trying to guess a specifically bound
protein/PTM). In this regard, ChAP-MS is a more cost-effective
option for characterizing specifically bound proteins and histone
PTMs relative to ChIP. Future derivations of this technology will
employ targeted mass spectrometric approaches for better
determination of combinatorial histone PTMs as well as identifi-
cation of other regulatory PTMs on nonhistone proteins from
these isolated sections (Taverna et al., 2007). Given the sensi-tivity of the mass spectrometry analysis employed and the rela-
tively modest biological starting material, our findings also
establish a framework for applying ChAP-MS to profile across
entire regions of chromosomes or investigate higher eukaryotic
systems. Direct adaptation of this technology in mammalian
cell lines may be difficult since targeted homologous recombina-
tion presents several challenges which may necessitate affinity
agents that do not require the incorporation of a DNA affinity
handle. In this regard, the use of DNA sequence-specific mole-
cules with strand invading properties like locked nucleic acids
(De´jardin and Kingston, 2009) or peptide nucleic acids (Boffa
et al., 1995) may circumvent these problems. However, some
major hurdles for using these approaches to purify a specific
locus may be the efficiency of strand invasion and the challenge
of targeting these moieties in conjunction with the chemical
crosslinking that is required to preserve the in vivo state of chro-
matin (Byrum et al., 2011a, 2011b). Regardless, any advances
that permit ChAP-MS analysis of in vivo untagged or unaltered
samples, like tissues, will undoubtedly have valuable applica-
tions for investigating altered gene transcription mechanisms in
humandisease states, as this technique could provide a compre-
hensive way to intelligently identify targets for therapeutics.
EXPERIMENTAL PROCEDURES
Construction of the LEXA::GAL1 pLexA-PrA Strain
The LEXA::GAL1 pLexA-PrA strain used to affinity enrichGAL1 chromatin was
designed to have a LexA DNA binding site just upstream of the GAL1 start
codon and contains a plasmid constitutively expressing a LexA-PrA fusion
protein. In S. cerevisiae from theW303a background, the GAL1 gene was ge-
nomically replaced with URA3 using homologous recombination. Next, the
GAL1 gene (+50 base pairs up- and downstream) was PCR amplified with
primers that incorporated a LexA DNA binding site (50-CACTTGATACTGTAT
GAGCATACAGTATAATTGC) immediately upstream of the GAL1 start codon.
This LEXA::GAL1 cassette was transformed into the gal1::URA3 strain andCell Reports 2, 198–205, July 26, 2012 ª2012 The Authors 203
selected for growth with 5-fluoroorotic acid, which is lethal inURA3 expressing
cells. Positive transformants were sequenced to ensure homologous
recombination of the cassette to create the LEXA::GAL1 strain. A plasmid
that constitutively expresses LexA-PrA fusion protein with TRP selection
was created by amplification of the PrA sequence from template pOM60 via
PCR and subcloning into the Sac1/Sma1 ends of the expression plasmid
pLexA-C. Transforming this plasmid into the LEXA:GAL1 strain gave rise to
the LEXA:GAL1 pLexA-PrA strain. Additionally, a control used in these studies
was W303a S. cerevisiae transformed only with pLexA-PrA.
Cell Culture
Strains LEXA:GAL1 pLexA-PrA and pLexA-PrA were grown in yeast synthetic
media lacking tryptophan to mid-log phase at 30C. LEXA:GAL1 pLexA-PrA
strain growths were done with isotopically light lysine, while strain pLexA-
PrA was cultured exclusively with isotopically heavy 13C6
15N2-lysine. For
each strain, 12 l of media containing either 2% glucose or 3% galactose
were grown to yield 5 3 1011 cells per growth condition. At mid-log phase,
the cultures were crosslinked with 1.25% formaldehyde for 5 min at room
temperature and then quenched with 125 mM glycine for 5 min at room
temperature. Cells were harvested by centrifugation (2,500 3 g) and frozen
in liquid nitrogen as pellets in suspension with 20 mM HEPES (pH 7.4), 1.2%
polyvinylpyrrolidone (1 ml/10 g of cell pellet). Frozen cell pellets were mixed
as follows at 1:1 cell weight ratios: (1) LEXA:GAL1 pLexA-PrA isotopically light
in glucose plus pLexA-PrA isotopically heavy control in glucose (2) LEXA:GAL1
pLexA-PrA isotopically light in galactose plus pLexA-PrA isotopically heavy
control in galactose. Cell mixtures were cryogenically lysed under liquid
nitrogen temperature with a Retsch MM301 ball mill (Smart et al., 2009; Tack-
ett et al., 2005a).
ChAP-MS Procedure
Each of the following two cell lysates were processed for purification of
GAL1 chromatin: (1) LEXA:GAL1 pLexA-PrA isotopically light in glucose
plus pLexA-PrA isotopically heavy control in glucose that will be referred to
as the glucose ChAP-MS and (2) LEXA:GAL1 pLexA-PrA isotopically light
in galactose plus pLexA-PrA isotopically heavy control in galactose that will
be referred to as the galactose ChAP-MS. Twenty grams of frozen cell lysate
(5 3 1011 cells) was used for each of the glucose and galactose ChAP-MS
analyses. ChAP-MS steps were performed at 4C unless otherwise noted.
Lysates were resuspended in 20 mM HEPES (pH 7.4), 1 M NaCl, 2 mM
MgCl2, 1 M urea, 0.1% Tween 20, and 1% Sigma fungal protease inhibitor
cocktail with 5 ml buffer per gram of frozen lysate. Lysates were subjected
to sonication with a Diagenode Bioruptor UCD-200 (low setting, 30 s on/off
cycle, 12 min total time) in 20 ml aliquots to yield 1 kb chromatin fragments.
Supernatants from sonicated lysates were collected by centrifugation at
2,000 3 g for 10 min. Dynabeads (80 mg) coated with rabbit IgG were added
to the lysates and incubated for 4 hr with constant agitation (Byrum et al.,
2012). Dynabeads were collected with a magnet and washed 5 times with
the purification buffer listed above and 3 times with 20 mM HEPES
(pH 7.4), 2 mM MgCl2, 10 mM NaCl, 0.1% Tween 20. Washed Dynabeads
were treated with 0.5 N ammonium hydroxide / 0.5 mM EDTA for 5 min at
room temperature to elute proteins. Eluants were lyophilized with a Savant
SpeedVac Concentrator. Lyophilized proteins were resuspended in Laemmli
SDS-PAGE loading buffer, heated to 95C for 20 min, resolved with 4%–20%
tris-glycine Invitrogen precast gels, and visualized by colloidal Coomassie
staining.
High-Resolution Mass Spectrometry and Data Analysis
Gel lanes were sliced into 2 mm sections and subjected to in-gel trypsin
digestion (Byrum et al., 2011a, 2011b, 2012; Tackett et al., 2005b). Peptides
were analyzed with a Thermo Velos Orbitrap mass spectrometer coupled
to a Waters nanoACQUITY liquid chromatography system (Byrum et al.,
2011b). Using a data-dependent mode, the most abundant 15 peaks were
selected for MS2 from a high-resolution MS scan. Proteins were identified
and the ratio of isotopically light/heavy lysine-containing tryptic peptide inten-
sity was determined with Mascot and Mascot Distiller. The search parameters
included: precursor ion tolerance 10 ppm, fragment ion tolerance 0.65 Da,
fixed modification of carbamidomethyl on cysteine, variable modification of204 Cell Reports 2, 198–205, July 26, 2012 ª2012 The Authorsoxidation on methionine, and two missed cleavages possible with trypsin. A
threshold of 95% confidence for protein identification, 50% confidence for
peptide identification and at least two identified peptides per protein was
used, which gave a 2%peptide false discovery rate. All specifically associating
protein identifications and ratios were manually validated.
A baseline was established for nonspecifically associated proteins with
nonspecifically enriched ribosomal proteins (Smart et al., 2009). The average
percent isotopically light peptides from 20 ribosomal proteins from the glucose
and galactose growth condition were used to establish this nonspecifically
associated baseline. This resulted in a nonspecifically associated baseline of
49.93% ± 2.12% light for the glucose ChAP-MS and 66.8% ± 7.1% light for
the galactose ChAP-MS. Proteins were categorized as specifically associating
if the percent light was greater than 2 SDs above the ribosomal level (Tables S6
and S7) (Smart et al., 2009). Duplicate ChAP-MS procedures showed Pearson
and Spearman correlation coefficient p values of < 0.001.ChIP and Gene Transcription Assays
ChIP and gene transcription assays were performed as previously reported
(Tackett et al., 2005b; Taverna et al., 2006). Assayswere performed in triplicate
and analyzed by real time PCR.SUPPLEMENTAL INFORMATION
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